Time trends of physician visits and treatment patterns of peptic ulcer disease in the United States

Archives of Internal Medicine

Volumn 157, Issue 13, 1997, Pages 1489-1494

  Munnangi, Sivakumar ^a   Sonnenberg, Amnon ^a,b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; BISMUTH SALICYLATE; CHOLINERGIC RECEPTOR BLOCKING AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROKINETIC AGENT; PROSTAGLANDIN DERIVATIVE; PROTON PUMP INHIBITOR; SUCRALFATE;

ARTICLE; CONSULTATION; DRUG CHOICE; MEDICAL PRACTICE; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

EID: 0030820705     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.13.1489     Document Type: Article

References (31)

1. Kurata JH, Corboy ED. Current peptic ulcer time trends: an epidemiological profile. J Clin Gastroenterol. 1988;10:259-268.
2. Gustavsson S, Kelly KA, Melton LJ III, Zinmeister AR. Trends in peptic ulcer surgery: a population-based study in Rochester, Minnesota, 1956-1985. Gastroenterology. 1988;94:688-694.
3. Walker LG Jr. Trends in the surgical management of duodenal ulcer: a fifteen-year study. Am J Surg 1988;155:436-438.
4. Bloom BS, Kroch E. Time trends in peptic ulcer disease and in gastritis and duodenitis: mortality, utilization, and disability in the United States. J Clin Gastroenterol. 1993;17:333-342.
5. Primatesta P, Goldacre MJ, Seagrott V. Changing patterns in the epidemiology and hospital care of peptic ulcer. Int J Epidemiol. 1994;23:1206-1217.
6. Sonnenberg A. Changes in physician visits for gastric and duodenal ulcer in the United States during 1958-1984 as shown by National Disease and Therapeutic Index. Dig Dis Sci. 1987;32:1-7.
7. Sonnenberg A, Koch TR. Physician visits for constipation in the United States: 1958 to 1986. Dig Dis Sci. 1989;34:606-611.
8. Everhart JE, ed. Digestive Diseases in the United States: Epidemiology and Impact. Washington, DC: US Government Printing Office; 1994:748. US Dept of Health and Human Services NIH publication 94-1447.
9. World Health Organization. International Classification of Diseases, Injuries and Cause of Death, Seventh Revision. Geneva, Switzerland: World Health Organization; 1958.
10. US Bureau of the Census, Population Division. United States Population Estimates, by Age, Sex, Race and Hispanic Origin, 1990 to 1995. Washington, DC: US Government Printing Office; 1974-1996. Release PPL-41. Current Population Reports, series P-25, Nos. 519, 917, 1022, 1045, and 1095.
11. Kahn HA, Sempos CT. Statistical Methods in Epidemiology. New York, NY: Oxford University Press Inc; 1989:87-95.
12. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311-1315.
13. Sonnenberg A. Dietary salt and gastric ulcer. Gut. 1986;27:1138-1142.
14. Kurata JH, Elashoff JD, Haile BM, Honda GD. A reappraisal of time trends in ulcer disease: factors related to changes in ulcer hospitalization and mortality rates. Am J Public Health. 1983;79:1066-1072.
15. Sonnenberg A. Peptic ulcer. In: Everhart JE, ed. Digestive Diseases in the United States: Epidemiology and Impact. Washington, DC: US Government Printing Office; 1994:357-408. US Dept of Health and Human Services NIH publication 94-1447.
16. Sonnenberg A, Everhart JE. The prevalence of self-reported peptic ulcer in the United States. Am J Public Health. 1996;86:200-205.
17. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1989;2: 1437-1442.
18. Rauws EA, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet. 1990;335:1233-1235.
19. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Intern Med. 1992;116:705-708.
20. Sudhop T, Breuer T, Goodman K, Graham DY, Malfertheiner P. Treatment of suspected gastroduodenal ulcer: is the German experience important for health policy decisions in the US? Gastroenterology. 1996;110:A42. Abstract.
21. Breuer T, Sudhop T, Goodman K, Graham DY, Malfertheiner P. Does disease presentation influence treatment of H pylori infection? a comparison of gastroenterologists and family practitioners. Gastroenterology. 1996;110:A69. Abstract.
22. Penston JG, Mistry KR. Eradication of H pylori in general practice. Aliment Pharmacol Ther. 1996;10:139-145.
23. Barton SGRG, Newton M, Hepworth CC, Carty E, Burnham WR. Reduction in relative incidence of duodenal ulcers: a long-term audit. Gut. 1996;38(suppl 1):A70. Abstract.
24. Peterson WL. Helicobacter pylori and peptic ulcer. N Engl J Med. 1991;324: 1043-1048.
25. Walsh JH. Helicobacter pylori: selection of patients. Ann Intern Med. 1992;116: 770-771.
26. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA. 1994;272:65-69.
27. Soll AH, Practice Parameters Committee of the American College of Gastroenterology. Medical treatment of peptic ulcer disease: practice guidelines. JAMA. 1996;275:622-629.
28. Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med. 1995;333:984-991.
29. Corthesy-Theulaz I, Porta N, Glauser M, et al. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology. 1995;109:115-121.
30. Sellman S, Blanchard TG, Nedrud JG, Czinn SJ. Vaccine strategies for prevention of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1995;7(suppl 1):S1-S6.
31. Editorial. Cimetidine for ever (and ever and ever . . .)? BMJ. 1978;1:1435.